 Wall Street analysts expect that Aptevo Therapeutics Inc NASDAQ:APVO will post 290,000.00 in sales for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Aptevo Therapeutics earnings. The lowest sales estimate is 190,000.00 and the highest is 400,000.00. Aptevo Therapeutics posted sales of 7.36 million in the same quarter last year, ... 